HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resistin in morbidly obese patients before and after gastric bypass surgery.

AbstractBACKGROUND AND OBJECTIVES:
Resistin was originally suggested to be a potential mediator of obesity-related insulin resistance in rodents. However, in humans, the role of resistin in obesity and insulin resistance has not yet been demonstrated. The present study investigates whether there are differences in resistin levels between patients with morbid obesity and lean subjects, and analyzes changes in resistin levels after significant weight loss secondary to bariatric surgery.
METHODS:
Sixty-eight patients with morbid obesity (body mass index [BMI] ≥ 40 kg/m2) and 31 lean subjects (BMI < 25 kg/m2) were selected. The study variables were: weight, height, BMI, waist-hip ratio (WHR), fat mass, family history of cardiovascular disease (CVD), type 2 diabetes mellitus (DM), hypertension, dyslipidemia, smoking, glucose, glycated hemoglobin (HbA1c), insulin, high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), adiponectin and resistin. Homoeostasis model assessment (HOMA) and quantitative insulin sensitivity check index (QUICKI) were calculated. The obese patients underwent gastric bypass surgery, and the above mentioned variables were reassessed after 12 months and major weight loss.
RESULTS:
There were no significant differences in resistin levels between morbidly obese patients and healthy subjects of normal weight, or between obese patients before and after weight loss. Resistin levels in morbidly obese patients were not correlated to adiposity anthropometric measures, insulin, glucose, HOMA, QUICKI, hsCRP, IL-6 or adiponectin. In the morbid obesity group, after one year of weight loss, the only study parameter correlated to resistin levels was IL-6.
CONCLUSION:
Our results do not support a relationship among resistin levels, obesity and insulin resistance in humans.
AuthorsElena Parreño Caparrós, Fátima Illán Gómez, Manuel Gonzálvez Ortega, Isabel Orea Soler, Matías Pérez Paredes, Maria Luisa Lozano Almela, Elena Arjonilla Sampedro, Marisol Alcaráz Tafalla
JournalNutricion hospitalaria (Nutr Hosp) Vol. 34 Issue 5 Pg. 1333-1337 (Sep 14 2017) ISSN: 1699-5198 [Electronic] Spain
Vernacular TitleResistina en obesos mórbidos antes y después de un bypass gástrico.
PMID29280648 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • RETN protein, human
  • Resistin
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • Body Mass Index
  • Female
  • Gastric Bypass
  • Healthy Volunteers
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Obesity, Morbid (blood, surgery)
  • Prospective Studies
  • Resistin (blood)
  • Thinness
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: